8. Pathogenesis
The primary disorder is an
increase in glomerular permeability to plasma proteins.
▲Foot processes of the visceral
epithelium of the GBM.
9. 1.The construction of the
glomerular basement membrane has changed.
2.The loss of the negative
charges on the
GBM.
10. ◆The underlying pathogenesis is unknown, but evidence
strongly supports the importance of immune mechanisms
(P328).
38. Middle-course & long-course
therapy:
① Induction of remission:
Prednisone 1.5~2mg/(kg · day)
(Max.60mg/day) for 4wk until
the urinary protein falls to
trace or negative levels
②
40. ▲Total course of treatment :
★Middle: 6mo
★Long: 9~12mo
Estimate of curative effect
(P331).
41. 3. Treatment of relapse and
recurrence
3.1 Extend the course of corticosteroid
3.2 Immunosuppressive agents
(Cytotoxic agents):
42. ① CTX (Cytoxan)
2mg/(kg·day) for 8~12wk .
Total amount: 250mg/kg
Side effects: nausea,
vomiting,
WBC↓, trichomadesis, hemorrhagic cystitis and the damage